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Early complications and endoleaks after
endovascular abdominal aortic aneurysm
repair: Report of a multicenter study
Jacob Buth, MD, PhD, and R.J.F. Laheij, MSc, PhD, on behalf of the
EUROSTAR Collaborators, Eindhoven, The Netherlands, and Liverpool, United
Kingdom
Objective: The aim of this study was the identification of risk factors for adverse events
and the assessment of the early success rate in 1554 patients with abdominal aortic
aneurysms (AAAs) who underwent treatment with endovascular technique between
January 1994 and March 1999. For this purpose, the clinical and procedural data were
correlated with observed complications and endoleaks.
Methods: The data were collected from 56 European centers and submitted to a central
registry. Patient characteristics, aortoiliac anatomic features, operative technical details,
types of devices used, and experience of the teams of physicians were correlated with the
occurrence of complications and endoleaks. The technical success rate was assessed
according to the Society for Vascular Surgery/International Society for Cardiovascular
Surgery, North American Chapter, guidelines. For the assessment of correlations between
risk factors and adverse events, a multivariate logistic regression analysis was used.
Results: The operative complications were grouped into three categories: failure to complete
the procedure (39 patients, of which 27 underwent a conversion to an open AAA repair;
2.5%); device-related or procedure-related complications (149 patients; 10%); and arterial
complications (51 patients; 3%). The most important risk factors for failure to complete the
procedure included an aneurysm diameter of 60 mm or more and the need for adjuvant pro-
cedures. The factors that predicted device-related and arterial complications were the expe-
rience of the team with endovascular AAA treatment and the need for adjuvant procedures.
Forty patients (2.6%) died within 30 days after operation. American Society of
Anesthesiologists III and IV operative risk classification results predicted higher mortality
rates than did American Society of Anesthesiologists operative risk classification I and II
results. The patients who underwent operation in 1994, the first year documented in this
registry, and those who required adjuvant procedures also had an increased risk of periop-
erative death. The incidence rate of systemic complications within the first 30 days (279
patients; 18%) was higher in patients aged 75 years or more, in patients with an impaired
cardiac status, and in patients considered unfit for an open procedure. An endoleak was
detected at the completion of the procedure in 16% of the cases and was still present after 1
month in 9%. The risk factors for primary endoleaks were female gender and age of 75 years
and older. The observed technical success rate in this patient series was 72%.
Conclusion: The learning curve of the doctors and the need for adjuvant procedures were
independent risk factors of operative device-related and arterial complications. The
importance of proper instruction during an institution’s initial phase with this treatment
is emphasized by these observations. Although the endovascular management of AAAs
is less stressful than open surgery, systemic complications were still the most common
adverse events during the first postoperative month. These complications were associat-
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The feasibility of endovascular repair of abdomi-
nal aortic aneurysms (AAAs) has been confirmed in
many studies. However, the reported incidence rate
of perioperative complications varies from 20% to
75%.1-8 This is considerable and warrants further
investigation. In the earliest series, some complica-
tions were attributable to inadequacies in the design
and construction of prototype devices. With the
evolution of improved endografts and delivery sys-
tems,9-11 patient-related and doctor-related risk fac-
tors for adverse events become relatively more
important and it is essential that these be identified
if results are to be improved further.
A number of conditions may be expected to
influence outcomes adversely (eg, the learning curve
of the operating team). Risk factors for adverse
events during the procedure might include need for
adjunctive endovascular or surgical procedures.
Potential patient-related factors that influence out-
come include age, previous symptoms of myocardial
ischemia, and anesthesia risk status. In addition,
there are factors that are related to the anatomy of
the aortoiliac segment.
This report documents the early results from a
multicenter registry of endovascular procedures 
for aneurysm repair that was organized by the
EUROSTAR (EUROpean collaborators on Stent-
graft Techniques for Abdominal aortic aneurysm
Repair) Collaborators Group. The purpose of the
registry was the assessment of the relative importance
of these factors for different categories of adverse
outcome. To allow the comparison of our results
with those of other studies, technical success was
assessed according to previously defined guidelines
for standardized reporting.12
MATERIALS AND METHODS
Study population and organization of the reg-
istry. In 1996, the EUROSTAR Registry was estab-
lished for the purpose of the collation and analysis of
data from patients who undergo endovascular treat-
ment for AAA. A study protocol and case record
forms were designed by an international steering
committee.13 Regular collaborators’ meetings were
organized to coincide with the annual congresses of
the European Society for Vascular Surgery. The sec-
retariat of the EUROSTAR organization is located at
the Royal Liverpool and University Hospital in
Liverpool, United Kingdom, and the Data Registry
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Center at the Catharina Hospital in Eindhoven, The
Netherlands. Fifty-six centers in 15 European coun-
tries have contributed data regularly to the registry.
Data on patients who underwent treatment before
September 1996 were collected and entered onto the
database retrospectively. This cohort of 362 patients
was identified separately as the retrospective part of
the registry. After September 1996, the pretreatment
registration of the patient became compulsory. These
patients (1192 until the closure of the study file) all
constituted the prospective part of the registry, which
accounts for 77% of the present data. All the com-
mercially available devices with a CE mark (European
Union regulatory approval) have been included.
According to the study protocol, the following infor-
mation was recorded: (1) preoperative patient and
anatomic characteristics, (2) operative details, (3)
types of devices used, and (4) outcome of the
angiogram at the completion of the procedure. The
data collected at follow-up examination included clin-
ical and imaging studies, with contrast-enhanced
computed tomography (CT) as the primary index
examination. The data were entered onto a comput-
erized database (written in Microsoft Access, version
2.0, Seattle, Wash) by a research secretary, and the
data analysis was undertaken by a data manager
(R.J.F.L.), who is a health scientist. The data manag-
er is in regular communication with the participating
centers to encourage maximum compliance with data
returns. He is also responsible for verifying the accu-
racy of the information submitted. The activity of the
Data Registry Center is overseen by a consultant vas-
cular surgeon, who reports regularly to the steering
committee. To date, financial constraints have pre-
cluded site visits by registry center staff and the estab-
lishment of a regular core laboratory for standardized
analysis of radiographic and CT images. Although the
absence of outside monitoring is undesirable in that it
may lead to variable standards of reporting, it was con-
sidered by the steering committee that know-how in
the evaluation of CT scanning and other imaging stud-
ies is widely available in institutions involved in the
EUROSTAR project. The financial support for this
project was initially from a Dutch government and a
hospital grant. However, most of the support has been
provided by fees charged for contracted reports for a
number of companies involved in stent-graft manufac-
turing (Boston Scientific, Natick, Mass; Medtronic,
Sunnyvale, Calif; and World Medical, Sunrise, Fla).
ed with several patient-related factors, including advanced age, impaired cardiac status,
and poor general medical condition. These observations may be a guide for improved
patient selection for endovascular AAA repair. (J Vasc Surg 2000;31:134-46.)
The inclusion criteria for this study, as defined in
the registry’s protocol, comprised an elective AAA
operation and an anatomic configuration suitable for
the implantation of a stented tube or a bifurcated
prosthesis. This configuration included an infrarenal
neck with a minimal length of 15 mm and iliac arter-
ies of adequate dimensions to admit the delivery sys-
tem. The exclusion criteria involved juxta or
suprarenal extension of the aneurysm, strong indica-
tions for combined reconstruction of other intra-
abdominal vessels, patients younger than 21 years,
connective tissue diseases, and active infection. The
baseline, demographic information collected included
the medical history, the preoperative vascular opera-
tive risk factors according to the Society for Vascular
Surgery/International Society for Cardiovascular
Surgery, North American Chapter (SVS/ISCVS) sys-
tem,14 brachial and ankle pressures, and anatomic
details of the aortoiliac segments. For the assessment
of the abdominal aorta and the iliac arteries, the
patients underwent contrast-enhanced CT scanning
and usually also angiography. The operative data
included details about the types of devices used, the
need for adjuvant procedures, device-related or pro-
cedure-related problems, arterial complications, and
the findings on completion angiography. In a small
number of patients, one or more items of data were
either missing or uninterpretable. Nevertheless, the
available data were sufficient to address most ques-
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tions in this study. Therefore, it was elected to use all
the available case record forms for this analysis.
Treatment. The operative details were recorded
according to the fixed format of the case record
form. The surgeons and radiologists were free to use
any device available for the endovascular exclusion of
AAAs. Included in this series were straight tube,
modular, and unipiece bifurcated and aortouniiliac
devices, either produced by commercial firms with
CE mark or fabricated in the institution itself. Most
participating centers were assisted during their first
series of cases by a vascular surgeon or radiologist
with extensive experience with the type of device
used. Most commonly, the procedures were per-
formed in the operating room with mobile fluo-
roscopy equipment. Completion angiograms were
performed for the assessment of the immediate
result of the procedure. In the great majority of cen-
ters, vascular surgeons and radiologists worked
together in teams. There were differences between
centers with regard to the use of systemic or region-
al heparinization and the application of coil
embolization of aortic side branches before endo-
graft implantation.
Postoperative examination. The period of
interest for this study was limited to the first post-
operative month. Information was recorded at the
end of the procedure, before discharge, and at 1
month. The results of the treatment were assessed
with clinical examination and with radiographic
imaging of the aneurysm and the endograft. All the
clinical complications were recorded together with
the presence and location of endoleaks. The assess-
ment at the end of the operation was performed
with completion angiography. CT examination with
contrast enhancement of the abdominal blood ves-
sels was carried out before discharge or at 1 month
after discharge. In a number of cases, CT imaging
was carried out at both of these intervals. Contrast
angiography, duplex scanning, and magnetic reso-
nance angiography examinations were used at the
discretion of the responsible physicians. In case
more than one examination was used, the ranking
order of the methods for analysis was: (1) CT, (2)
angiography, (3) magnetic resonance angiography,
and (4) duplex scanning. The highest ranking
method used was the recorded examination.
Outcome events. The outcome events that
were registered in the case record forms were oper-
ative complications (events occurring during the
procedure) and postoperative complications (events
occurring during admission or within the first post-
operative month). The operative complications were
Table I. Operative complications (during stent
graft procedures) in 1554 patients
No. of No. of 
patients complications 
(%) (%)
Failure to complete procedure 39 (2.5)
Conversion to open procedure 27 (2)
Extra-anatomic bypass grafting 9 (0.6)
Other (abandoning the procedure) 3 (0.2)
Device-related complications 149 (10)
Inability to advance delivery system 32 (2)
Inability to deploy device 26 (2)
Device/device limb occlusion, 16 (1)
stenosis, or kinking
Device migration 25 (2)
Balloon burst or other problem 24 (2)
Delivery sheath tear, device stuck 18 (1)
in sheath
Other 28 (2)
Arterial complications 51 (3)
Arterial damage, perforation, 23 (1.5)
rupture, dissection
Thrombus, obstruction, stenosis 12 (0.7)
Emboli 5 (0.3)
Occlusion of renal artery 2 (0.1)
Other 10 (0.6)
three grades: first to 10th operation, 11th to 30th
operation, and more than 30 operations performed.
Discrete variables are presented in absolute numbers
or percentages of each subgroup. Continuous vari-
ables are expressed as median values and interquar-
tile ranges (IQRs). These variables were first corre-
lated with univariate analysis with the outcome
events by means of χ2 test. The Mann-Whitney test
was used for continuous parameters. Significantly
associated variables were subsequently selected step-
wise (backward selection) for a multivariate logistic
regression model, which was tested for stability of
the coefficients and their standard errors.17 The
results of the different variable-to-outcome event
correlations are expressed as odds ratio (OR) with
corresponding 95% confidence interval (CI).
Statistical significance was reached if the P value was
less than .05. All the analyses were performed with
SAS statistical software (version 6.12, SAS Institute,
Inc, Cary, NC).
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subdivided into three categories: (1) failure to com-
plete the procedure, (2) device-related, and (3) arte-
rial complications. The different adverse events
within these categories are specified in Table I. The
postoperative complications were categorized into:
(1) systemic, (2) procedure-related and device-relat-
ed, and (3) access site and lower limb complications.
The details of these outcome events are presented in
Table II. The 30-day mortality rate was recorded as
a separate outcome event.
Endoleaks were analyzed at two points of time—at
the end of the procedure as documented with com-
pletion angiography and during the first postoperative
month. If a patient underwent two examinations with-
in the first 30 days, one before discharge from the hos-
pital and the other at the scheduled 1-month visit, the
findings of the second CT scan were recorded.
Endoleaks are categorized into four types as described
by White et al.15 Type I endoleaks involve proximal
and distal attachment site endoleaks, and type II rep-
resent reperfusion via lumbar or inferior mesenteric
arteries. Type III are graft-site endoleaks, including
leakage at the connection of the separate iliac limb to
the body of the device and fabric holes. Type IV
include blushing via the pores of the device fabric. The
overall technical success rate was calculated with the
guidelines of the advisory committee of the
SVS/ISCVS.12 The key elements included in technical
success are: successful access, successful deployment
(with persisting perigraft endoleakage other than
transgraft extravasation considered failure), and patent
endoluminal graft.
Data analysis. A set of 16 variables was corre-
lated with the outcome events described previous-
ly. These variables were: patient factors (gender,
age, American Society of Anesthesiologists [ASA] clas-
sification,16 consideration as unfit for open surgery,
ankle and arm blood pressure index, and cardiac
status and smoking—both scored according to the
SVS/ISCVS risk scoring system14), anatomic
dimensions (infrarenal neck diameter, maximum
aneurysm diameter, severe angulation of the iliac
arteries), procedural aspects (need for adjuvant pro-
cedures, duration of the procedure, which was only
considered for correlation if it was likely not to be a
result of the outcome event), physician-related fac-
tors (level of experience of the team), study period
(retrospective versus prospective part of the study,
calendar year 1994 to 1999), and type of device
(company label). Experience with the procedures in
each institution was calculated on the basis of the
sequence and number of patients enrolled in the
EUROSTAR Registry. Experience was ranked into
Table II. Postoperative complications (during
admission and in the first postoperative month)
No. of No. of
patients complications
(%) (%)
Systemic complications 279 (18)
Cardiac 71 (5)
Pulmonary 50 (3)
Renal 54 (3)
Cerebral 24 (1.5)
Hepatobiliary 5 (0.3)
Gastrointestinal 34 (2)
Sepsis, prolonged fever 52 (3)
Other 71 (5)
Laparotomy for systemic 8 (0.5)
complications
Procedure-related and device-related 76 (5)
complications
Graft migration 7 (0.5)
Graft stenosis 6 (0.4)
Graft (limb) thrombosis 24 (1.5)
Bleeding perianeurysmal (rupture or —
perforation)
Secondary interventions transfemoral 25 (1.6)
Secondary interventions transabdominal 14 (0.9)
Secondary interventions extra-anatomic 13 (0.8)
Access site and lower limb 143 (9)
complications
Bleeding, hematoma, false aneurysm 86 (5)
Arterial thrombosis 6 (0.4)
Peripheral emboli 10 (0.6)
Intermittent claudication 5 (0.3)
Limb loss 2 (0.1)
Femoral nerve neuralgia 6 (0.4)
Wound infection, lymphocele, 20 (1)
lymphatic fistula
Other 9 (0.6)
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RESULTS
Patients, devices, and procedures. Between
January 1994 and March 1999, 1554 patients from 56
centers were included in the registry (from three to
287 patients per center). Of these patients, 1421 were
male and 133 were female. In this study group, 362
patients were included in the retrospective part of the
registry and 1192 in the prospective part. At the time
of the closing of the patient file for this analysis, 43
additional patients who were included in the prospec-
tive part had been registered more than 3 months ear-
lier, but operative data had not yet been received.
These patients could not be considered for this study.
The mean age of the patients was 70 years (range, 37
to 90 years). The median size of the aneurysms was 56
mm (range, 28 to 150 mm). The baseline medical
characteristics and the risk factors were fairly typical for
patients with AAA who undergo treatment, except for
the fact that 7% of the study population was classified
as ASA IV (Table III).
Of the patients, 1387 underwent placement with
a modular bifurcation device, 42 with a one-piece
bifurcation device, 98 with an aorto-aortic straight
tube endograft, and 27 with an aortouniiliac device
combined with a femorofemoral bypass graft. The
commercial devices used were: Stentor (Mintec,
Freeport, Bahamas; 330 patients), Vanguard (Boston
Scientific; 741 patients), EVT (Endovascular
Technologies, Menlo Park, Calif; 52 patients), Talent
(World Medical; 160 patients), AneuRx (Medtronic;
215 patients), and other labels or physician-con-
structed devices (56 patients). Straight tube devices
were used in the Stentor group in 33 patients (10%),
in the Vanguard group in 30 patients (4%), in the
EVT group in 12 patients (23%), in the Talent group
in 16 patients (10%), in the AneuRx group in two
patients (1%), and in the other devices group in five
patients (9%). In 444 patients, 508 adjuvant proce-
dures were performed (Table IV).
Complications during the procedure. One hun-
dred ninety-one patients (12%) had operative compli-
cations: 146 had complications in one category, 42
had complications in two categories, and three had
complications in three categories (Table I). Failure to
complete the endovascular procedure was reported in
2.5%. Conversion to an open procedure was necessi-
tated by device migration, inability to cannulate the
short limb, aortic rupture, arterial dissection, and per-
foration. Primary extra-anatomic bypass grafting was
undertaken for iliac artery or device limb occlusion.
The procedure was abandoned on three occasions
when the device fell back into the sack or because it
impacted during deployment (Table I). In the multi-
variate analysis results, the aneurysm diameter was the
only anatomic variable that had an adverse indepen-
dent correlation with outcome. Age of 75 years or
older, the need for adjuvant procedures, and two of
the device types used had a negative influence on this
outcome event (Table V). There were 9.6% (5 of 52)
failures to complete the procedure in patients with
EVT and 7.5% (12 of 160) with Talent as opposed to
Table III. Risk factors in 1554 patients who
underwent stent graft treatment for abdominal aor-
tic aneurysm
SVS/ISCVS risk score
0 1 2 3
Associated diseases Percent of patients
Diabetes mellitus 90 8 2 0.2
Smoking 43 30 18 9
Hypertension 43 38 16 3
Hyperlipidemia 60 26 5 9
Cardiac status 39 30 26 5
Carotid disease 84 11 3 2
Renal status 83 14 2 1
Pulmonary status 64 21 12 3
ASA physical status classification No. of patients (%)*
ASA I 128 (8)
ASA II 594 (39)
ASA III 677 (45)
ASA IV 108 (7)
SVS/ISCVS, Society of Vascular Surgery/International Society of
Cardiovascular Surgery, North American Chapter; ASA,
American Society of Anesthesiologists classification.
Overall reporting rate of the different risk scores was 95%.
*The ASA classification was not retrieved in 47 patients.
Table IV. Adjuvant procedures in 1554 patients
who underwent stent graft treatment for abdomi-
nal aortic aneurysm (n = 444)
No. of 
procedures
Percutaneous transluminal angioplasty (or stent) 250
Endarterectomy, arterial reconstruction, or repair 57
of CFA/iliac artery damage
Embolization of side branches 66
Femoropopliteal bypass graft 6
Decoiling of iliac arteries 11
Iliofemoral bypass graft for access 8
Banding of iliac arteries 3
Crossover femorofemoral bypass graft 26
Ligation of common iliac arteries 5
Intentional crossing of renal arteries by uncovered stent 23
Hypogastric arterial bypass graft or reimplantation 11
Ligation of hypogastric artery 4
Other (arterial procedures) 35
Other nonarterial procedures 3
CFA, Common femoral artery.
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1.6% (22 of 1342) with all other devices combined.
For the assessment of whether different proportions of
straight tube or aortouniiliac graft device diameters
were responsible for the difference in outcomes, graft
configuration was entered as an additional variable
into the logistic regression model. The expanded
model failed to show device configuration as a signifi-
cant factor in procedural failure, and the other correla-
tions were similar to those in the original model.
In device-related complications, which occurred
in 10% of the patients, the following variables corre-
lated significantly with outcome: current smoking,
the need for adjuvant procedures, and experience of
the team (Table V). Institutional experience was
associated with an increase in complications (inci-
dence rate, 14%) between the 10th and the 30th
procedure as compared with the initial 10 operations
(incidence rate, 7%). After 30 patients underwent
treatment, the incidence rate of complications (7%)
was similar to that of the initial patient group.
Arterial complications were observed in 3% of
the patients. In the multivariate regression model
results, the experience of the operating team and the
need for adjuvant procedures correlated indepen-
dently with the occurrence of arterial complications.
The frequency of arterial complications decreased
significantly with growing experience, the incidence
rate being lowest after 30 operations (Table V). ASA
class IV and aneurysmal diameter also had an
adverse effect on the rate of arterial complications,
although this did not reach statistical significance.
Mortality and other complications within the
first postoperative month. There were 40 deaths
within the first postoperative month, for a periopera-
tive mortality rate of 2.6%. The causes of death includ-
ed cardiac failure (the most frequent cause of death
with 12 patients [30%]), multiorgan failure/sepsis,
adult respiratory distress syndrome, aortic perforation,
pulmonary failure, and stroke. Six of the deaths (15%
of the total deaths) occurred in patients who had
undergone conversion to open repair. The mortality
rate in the patients in whom conversion was necessary
was 22% (6 of 27). In the multivariate model, ASA
classes 3 and 4 (P = .04 and P = .0001; OR, 2.3 and
6.8; 95% CI, 1.0 to 5.2 and 2.7 to 17.4, respectively),
the need for adjuvant procedures (P = .008; OR, 2.49;
95% CI, 1.3 to 4.9), and the calendar year 1994 (P =
.001; OR, 8,8; 95% CI, 2.5 to 32.5) were found to
Table V. Results of multivariate analysis relating risk factors to the probability of categorized complications
observed during procedures
Variable P value Odds ratio 95% Confidence interval
Failure to complete the Patient age (years) ≤65 — 1 1
procedure 65 - 75 .44 1.48 0.54 - 4.06
≥75 .02 3.28 1.25 - 8.61
Aneurysm diameter (mm) <60 — 1 1
≥60 .005 2.72 1.36 - 5.45
Adjuvant procedure No — 1 1
Yes .0003 4.48 2.24 - 8.98
Type of device Vanguard — 1 1
Stentor .8 0.87 0.28 - 2.75
AneuRx .5 0.64 0.18 - 2.32
Talent .0006 4.40 1.90 - 10.23
EVT .0003 8.21 2.64 - 25.55
Other devices .5 1.65 0.35 - 7.84
Device-related Smoking risk score 0 — 1 1
complications 1 .75 1.07 0.71 - 1.60
2 & 3 .01 0.46 0.25 - 0.83
Adjuvant procedure No — 1 1
Yes .001 1.79 1.25 - 2.55
Experience of team ≤10 — 1 1
(procedures) 10 - 30 .006 1.80 1.18 - 2.74
≥30 .4 0.84 0.53 - 1.31
Arterial complications Adjuvant procedure No — 1 1
Yes .0001 3.83 2.10 - 7.01
Experience of team ≤10 — 1 1
(procedures) 10 - 30 .5 0.82 0.42 - 1.58
≥30 .006 0.34 0.16 - 0.74
The odds ratio is relative to the variable’s reference class, which is indicated by odds ratio = 1.
Smoking risk score is indicated according to the Society of Vascular Surgery/International Society of Cardiovascular Surgery, North
American Chapter Ad Hoc Committee.14
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have an independent correlation with death within 30
days. In patients with ASA class IV, there were 11
deaths (10.2%), as opposed to 29 deaths (2.1%) for the
patients with a lower ASA classification (P = .001).
There was a progressive increase in mortality risk with
ascending ASA grading. For patients in ASA I, there
were no deaths, and for those in ASA II and III, the
mortality rates were 1.5% and 2.9%, respectively. The
mortality rate was higher during the calendar year
1994, when the first cohort of 31 patients included in
this registry underwent treatment (mortality rate,
12.9% [4 of 31 patients]; vs 2.4% [36 of 1481 patients]
in the combined other years; P = .001).
The postoperative complications recorded up to
the end of the first month were separated into the
three categories indicated in Table II. Of the patients,
377 (24%) had complications recorded: 267 had
complications in one category, 99 in two categories,
and 11 in three categories. The factors that were asso-
ciated with systemic complications comprised age
more than 65 years, a cardiac risk score of 2 or 3, a
consideration of unfit for open surgical AAA repair,
any adjuvant procedure being performed, and dura-
tion of the operation (Table VI). The duration of the
procedure was 160 minutes (IQR, 120 to 220 min-
utes) in patients with systemic complications and 130
minutes (IQR, 100 to 180 minutes) without compli-
cations. Two preoperative variables had a particularly
strong effect with ORs of 2 or greater—age and con-
sideration of unfit for open surgery. It appeared in this
series that patients of 75 years or older who were con-
sidered unfit for an open procedure had a 42% risk of
systemic complications, as opposed to only 11% risk in
fit patients of 65 years or younger.
Procedure-related and device-related complica-
tions included 14 secondary transabdominal inter-
ventions (Table II). These operations involved con-
version to conventional repair in eight patients,
control of bleeding in two patients, arterial recon-
Table VI. Results of multivariate analysis relating risk factors to the probability of categorized complica-
tion within the first postoperative month
Variable P value Odds ratio 95% Confidence interval
Systemic complications Age (years) ≤65 — 1 1
65 - 75 .03 1.56 1.28 -1.91
≥75 .0008 2.00 1.63 - 2.47
Cardiac status 0 — 1 1
1 .3 1.23 1.01 - 1.49
2 & 3 .01 1.60 1.32 - 1.92
Unfit for open surgery No — 1 1
Yes .0005 2.01 1.65 - 2.46
Adjuvant procedure No — 1 1
Yes .005 1.57 1.34 - 1.85
Duration of procedure* .0001 — —
Procedure-related and device- Year of procedure 1998 - 1999 — 1 1
related complications 1997 .8 1.07 0.59 - 1.93
1996 .003 2.40 1.35 - 4.27
1995 .277 0.51 0.15 - 1.72
1994 .8 0.77 0.10 - 5.89
Access site and lower limb Adjuvant procedures No — 1 1
complications Yes .0001 3.54 1.96 - 6.39
Experience of team ≤10 — 1 1
(procedures) 10 - 30 .8 0.92 0.48 - 1.77
≥30 .03 0.42 0.20 - 0.91
The odds ratio is relative to the variable’s reference class, which is indicated by odds ratio = 1.
*Continuous parameter.
Table VII. Endoleaks at completion angiogram
and within the first month after surgery
At completion Within first month
angiography after surgery
Total no. of patients 1554 1471*
Patients with first obser- 250 86
vation of endoleak
Patients with a persistent — 63
endoleak
Patients with resolved endoleak — (186)
Proportion of patients with 250 (16%) 149 (10%)
endoleak
*Of patients who underwent initial treatment, 83 had end of their
follow-up period within the first month because of death (34
patients), early conversion (21 patients), death and early conver-
sion (six patients), and missing imaging study (22 patients).
struction in three patients, and a laparotomy for a
septic complication in one patient. In this category
of complications, the calendar year in which the ini-
tial procedure was performed was the only factor
that had a positive correlation. This correlation
involved a higher risk for patients who underwent
operation in 1996 (Table VI).
Access site and lower limb complications were
more often observed if adjuvant procedures had been
required during the initial operation. Experience of
the operating team also had an influence on the risk
of complications, with a decrease after the perfor-
mance of 30 procedures.
Endoleaks. At completion angiography, 250
patients (16%) had a total of 260 endoleaks. One
hundred and fourteen (43%) were type I endoleaks,
91 (35%) were type II, 19 (7%) were type III, and
22 (8%) were type IV. In 14 patients (5%), the site
of the endoleak was uncertain. The univariate and
multivariate analysis results indicated that female
gender (P = .02; OR, 1.7; 95% CI, 1.1 to 2.7) and
a patient’s age of 75 years or older (P = .0009; OR,
1.9; 95% CI, 1.3 to 2.9) were significant risk factors
for endoleak. It is of note that the current smokers
had a lower incidence rate of endoleak than did the
non-smokers, 6.11% versus 10.9%, respectively (P =
.02; OR; 0.45; 95% CI, 0.2 to 0.9).
The fate of the endoleaks for the period up to 1
month after operation was studied. The proportion
of patients with endoleaks that had resolved at 1
month was 74% (186 of 250), and 25% (63 of 250)
had persisting endoleaks (Table VII). On the other
hand, during the same period, 86 patients had a new
endoleak develop, as shown with CT examination
results. With the inclusion of these patients, a total
of 149 patients exhibited evidence of endoleak at 1
month. This equates to 10% of the whole cohort of
patients. Persisting endoleaks were less frequently
observed with type II endoleaks than with other
types of endoleaks (15% [13 of 85] vs 30% [50 of
165]; P = .02).
Technical success rates. Death, failure to com-
plete the procedure (including conversions), device
(limb) occlusions, secondary transabdominal inter-
ventions, extra-anatomic bypass grafting, aneurysm
perforation, or endoleaks (excluding type IV)
occurred in 437 patients, which resulted in a 72%
technical success rate. All the patients were counted
in the technical failure category at their first event.
Twenty-two patients underwent only a predis-
charge examination but did not experience any
events during their hospital stay. These patients
were included in the technical success group.
DISCUSSION
The EUROSTAR Registry was established to
gather large amounts of data as quickly as possible for
the assessment of the efficacy of treatment of AAAs
with endovascular techniques. One advantage of the
pooling of data from a large number of departments
is that it permits the extensive analysis of subgroups.
An additional advantage of a multicenter registry is
that the tendency for the selective reporting of good
outcomes may be less. It has been observed previ-
ously that multi-institutional AAA studies report
higher complication rates than do publications on
the experiences of single institutions.18
A high incidence of early adverse events has a rel-
atively greater negative effect on the well being of
the patients and health care resources than do longer
term complications. This is because most patients
are exposed to the possibility of early complications,
but only those who live long enough are subjected
to later risks. This very detailed study of operative
and early complications associated with endovascular
aneurysm repair is, therefore, of considerable rele-
vance to clinical practice.
Operative complications. Technical mishaps
that precluded the completion of the procedure were
caused by arterial injury and inability to gain access
or to deploy the device at the planned site.
Procedural failure resulted in conversion to open
repair in 27 patients (1.7%). This rate is in the same
range as the 2% reported by Stelter et al7 and slight-
ly lower than the 3% and 4% reported recently by
other investigators.19,20 In the published series that
included the early experience with endovascular AAA
treatment, the conversion rate was considerably high-
er, ranging from 7% to 18%.4,21,22 The low conver-
sion rate in this registry population may reflect the
large proportion of patients who underwent treat-
ment in more recent years and the benefits of effec-
tive supervision and instruction during the learning
curve by an increasing number of available experi-
enced physicians. Our observation, that conversion is
associated with a perioperative mortality rate as high
as 22%, is in agreement with the 11% to 22% report-
ed in previous studies.20,23,24 Technical complica-
tions that precluded the completion of the procedure
were associated with advanced age, large aneurysm
diameter, and the need for adjuvant procedures, all
factors that may reflect the complex anatomy of the
aneurysms. EVT and Talent prostheses were associat-
ed with a higher risk of procedural complications
than were other makes of device. It should be
emphasized that some aspects that influenced device
performance were not included in this analysis. For
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example, a higher proportion of straight tube grafts
in the EVT group might have been responsible for
the relatively high incidence of problems encoun-
tered. However, an additional multivariate compari-
son failed to showed device configuration to be a sig-
nificant predictor of procedural failure. May et al25
also found that straight tube grafts did not correlate
with a greater risk of primary conversions, although
they were associated with more endoleaks and sec-
ondary conversions. It should be noted that many
EVT devices in this registry were implanted between
1994 and 1996 (ie, they constituted a relatively high
proportion of the early experience). The latest mod-
ification of the EVT devices makes them easier to use
than the earlier models, and low complication rates
have recently been reported by other investigators.26
It is known that the Talent endografts are used fre-
quently in larger sizes that are not offered by other
manufacturers. This indicates that they are used more
often in patients with wide and short infrarenal necks.
With the availability of aortic extension cuffs, the
problems of migration during the procedure can now
be resolved. Thus, there are factors that can be iden-
tified that relate to the use of both the EVT and the
Talent devices that may explain the relatively high
rate of associated complications. It would be unrea-
sonable to conclude that they are any less efficient
than are any other currently available devices on the
basis of these data alone.
Device-related or procedure-related complications
and arterial complications during the operation were
most clearly related to the need for adjuvant interven-
tions and to the experience of the physicians. The for-
mer is likely to be a reflection of adverse anatomy. At
first sight, it seems curious that the second phase of
the learning period (from the 10th to the 30th pro-
cedure) was associated with the greatest risk of com-
plications rather than the first phase. Perhaps during
the first series of procedures, proctoring helped to
prevent serious problems, but during the second
phase, the team experienced its actual learning curve.
Alternatively or additionally, increased confidence
may lead to widening indications and the inclusion of
less ideal patients. In contrast, arterial complications
occurred significantly more often in the initial 30
patients of an institution’s experience. It may well be
that during this period more attention was paid to the
endovascular procedure than to the details regarding
arterial access.
First month mortality and morbidity. The
overall mortality rate of 2.6% was approximately in
the middle of the range of the 0 to 6.6% rate that was
reported in recent studies on endovascular AAA
repair.7,10,11 The few studies that compared patients
who underwent treatment with endografts with a
contemporary group of controls who underwent
treatment with open surgery showed no difference in
mortality rate.27-29 However, these series were too
small for a meaningful comparison of the incidence
of death between the two treatments. The observed
mortality rate in this registry compares favorably with
the rates that were obtained from the pooled data of
multicenter studies of the results of open AAA repair
(8.2% and 7.4% in prospective and retrospective stud-
ies, respectively), and they are comparable with the
outcome in the hospital-based studies (3.8%).18
Although the patient numbers in this study are large,
a different distribution of risk factors as compared
with the risk factors of other series cannot be ruled
out. The issue of selection bias can only be resolved
in a large-scale randomized study.
The positive correlation of ASA classifications III
and IV as indicators of the general medical status
with the increased risk of mortality is not surprising.
However, there was no correlation between specific
cardiac risk factors and death. This is in contrast to
the usual findings in studies on open AAA
surgery.30-32 The proportion of cardiac deaths as
opposed to deaths from other causes (12 of 40;
30%) in this patient series was low in comparison
with the 60% normally associated with conventional
operations.30,33,34
Systemic complications in this series occurred in
18% of the cases, which is comparable with the 11% to
20% reported in other series of patients who under-
went treatment with endovascular technique.5,28,35
The prevalence of systemic complications as found in
this study has been compared with that reported in
prospective multicenter studies of open AAA repair.18
Most types of complication occurred less frequently in
patients who underwent treatment with endovascular
repair. For example, the rate of cardiac complications
was 5% versus 11%, the rate of pulmonary complica-
tions was 3% versus 5.3%, and the rate of renal com-
plications was 3% versus 7%. In the case of endovascu-
lar repair, the risk factors for all systemic complications
together were similar to those for cardiac events in
studies on open aortic surgery. These factors were an
impaired preoperative cardiac risk score and poor gen-
eral medical condition. Additional factors, such as pro-
longed duration of the operation and advanced age,
were also found to apply in studies on open aneurysm
surgery.32
The 9% incidence rate of complications related to
access site and lower limb was lower than those rates
in earlier series, which approximate to 20%,11,29 but
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similar to the 5% to 8% reported in more recent
series.7,10,27 Chuter et al4 experienced a 40% inci-
dence rate of local and arterial complications in the
first 20 patients as opposed to 0% in the second 20
patients in their study group. Increasing experience
with endovascular AAA treatment had a beneficial
effect on this type of complication in this series also.
The approach to training in endovascular AAA treat-
ment has recently attracted considerable interest.
Sophisticated flow models for practicing are now
available,36 and the interest in hands-on training ses-
sions is considerable. It is likely that the increased
access to well-structured training facilities will make
the learning curve shorter and smoother.
Endoleaks. The presence of endoleaks may be
associated with the subsequent expansion of the
aneurysm and possible rupture.37-39 The 16% inci-
dence rate of early endoleaks that was found in this
registry is in the middle of the reported range, which
varies from 12% to 44%.1,7,10,11,21 Two factors inde-
pendently favored an increased incidence of endoleak:
advanced age and female gender. Increasing age may
be associated with more complex anatomy, although
none of the anatomic variables investigated were
found to be predictive of endoleakage. The higher
incidence of endoleaks associated with female gender
may be related to as yet undetermined factors, intrin-
sic to the aneurysm, to the vessel wall, or to the
blood. In addition, the coagulation profile, on which
we have no information in this study, may be a signif-
icant factor, especially with respect to type II
endoleaks.40 It was surprising to find that current
smokers had a smaller risk of endoleaks than did non-
smokers. The mechanical properties of the vessel wall
or the patterns of distribution of the thrombus with-
in the aneurysm sac may have some influence, but the
reason for this association is unknown.41
Most (71%) of the endoleaks that we observed at
the completion angiogram had disappeared within the
first month. Other investigators have found a compa-
rable decrease.9,27 A useful classification of endoleaks
has been proposed by White et al.15 These authors dis-
tinguished four types of endoleaks. We observed a
lower incidence of persisting endoleaks in type II
endoleaks than in other types of endoleaks. This find-
ing is different from the findings of Matsumura and
Moore,42 perhaps because of the greater numbers of
patients in this series. There is concern that thrombus
sealing of an endoleak may still be able to transmit
pressure to the aneurysm sac. Therefore, patients with
self-sealed endoleaks require continued careful follow-
up examination. Further expansion of the aneurysm is
a clear indication that it is still pressurized.
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Technical success. The overall technical success
rate, as defined by the Ad Hoc Committee of the
SVS/ISCVS,12 was 72%, which is in the same range as
the 77% obtained in a recently reported controlled
study.27 This outcome measure includes successful
access and deployment in addition to absence of
endoleak and patency of the graft. For technical suc-
cess, the result must be maintained for a minimum
period of 1 month without death or the need for open
aortic reconstruction. The assessment of outcome
must be made on an intent-to-treat basis. The
EUROSTAR Registry adheres to these principles.
The pretreatment registration of the intended proce-
dure is mandatory. Nevertheless, the operative data of
43 enrolled patients (2.7%) were not retrieved and, in
a worst case scenario, with the assumption of an
adverse event in all these patients, the technical suc-
cess rate would have been 69%. Of 22 additional
patients, the 1-month results were not known.
However, an uneventful procedure and admission
period was recorded in all of these patients and it has
been assumed that no problems occurred within the
first month.
Technical success according to the previous defi-
nition was not used in most previous institutional
multicenter reports, and this precludes comparison
with this series. The use of this outcome parameter
in future reports is recommended because it repre-
sents the 1-month procedural results on the basis of
a combination of events that all can be assessed
objectively. Nevertheless, it provides a rather tech-
nique-oriented parameter, and the chance of success
as viewed by the patient may be rather different.
After all, a technically failed procedure, followed by
the successful management of endoleak or graft limb
occlusion, still renders endovascular repair preferable
to open surgery.43
CONCLUSION
Despite the minimal invasive nature of endovascu-
lar aneurysm repair, a variety of complications do
occur with considerable frequency. The probability of
technical complications that preclude the completion
of the procedure is increased in large aneurysms and
by the need for adjuvant procedures. The patient’s
age and cardiac and general medical status have an
important influence on the risk of systemic complica-
tions. The experience of the operating team is an
important factor influencing the risk of device-related
or procedure-related adverse events. These findings
underline the importance of adequate training and
may help to guide the selection of patients and devices
for endovascular AAA repair in the future.
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Dr Juan C. Parodi (Buenos Aires, Argentina). After
briefly reviewing the manuscript, I believe that Dr Buth
and his colleagues should be commended for obtaining
reasonable conclusions from a complex database.
The aim of this study was to identify the risk factors for
adverse events and to assess the early success rate in 1554
patients with abdominal aortic aneurysms who underwent
treatment with endovascular technique. The EUROSTAR
Registry database has multiple variables, most of them
related to each other. The database, as it is, has an obvious
potential value representing the reality of the clinical prac-
tice. I am not sure that the conclusions that can be raised
on the basis of this database are very valuable.
In terms of the use of this data for analysis, let us briefly
analyze the following weaknesses of the EUROSTAR
Registry: (1) the lack of independent audit, (2) the mixture
of retrospective and prospective data, (3) the inclusion of
56 centers with quite different experiences in the field and
different technical capabilities, (4) the inclusion of patients
of quite different categories in relation with risk factors, (5)
the inclusion of homemade and commercially available
devices, (6) the inclusion of five different commercially
available devices, and (7) the use of different ways of eval-
uation with different imaging methods.
In any event, the results were acceptable. The conver-
sion rate was 1.7%, the mortality rate was 2.6%, the sys-
temic complications were 18%, and the device-related and
procedure-related complications were 10%. The authors
reported endoleaks in 16% of the patients, with 43% type
I, and in 9% after 1 month. We believe that the subsequent
evolution of the patient with type I endoleak, even sealed,
represents a failure of the procedure. This assumption
invalidates the evaluation of success in this series.
In conclusion, I believe that we can take these data as
a general idea of what the problems are and accept the lim-
itations of the analysis.
I have only one question, which is, what controls do
you use in terms of imaging quality?
Thank you.
Dr Jacob Buth. Thank you very much, Dr Parodi.
Thank you especially for your willingness to review this on
such short notice.
We think that the EUROSTAR Registry does reflect
the reality of the practice of endovascular AAA treatment
in several countries. We consider that most of the argu-
ments that you put forward just reflect the reality that one
likes to see. Our study shows that there are considerable
differences in experience between institutions and that
these differences matter for the procedural outcome. Also,
there are differences in risk factors of patients who under-
go treatment and there are differences in imaging meth-
ods between one or another hospital. This also belongs to
the real practice, and we have to take these factors into
account. In our opinion, knowledge of healthcare is more
served by studying the actual practice patterns than the
outcome of a single center of excellence.
With regard to a number of other flaws that you indi-
cated, it is correct that there was no audit of patient data.
It would simply be beyond practical possibilities to have
available the large number of monitors required for a
study of this size. Although the study includes a number
of patient groups that have been monitored, in essence
this is a non-audited study. We think that this may be com-
pensated by the large study group and by good feedback
between the individual participants and the data registry
center.
In this study, we have not discriminated between the
group of 360 patients who were enrolled retrospectively
and the 1200 patients from whom the data had been col-
lected prospectively. In an earlier study, which was reported
in a poster at the Society for Vascular Surgery/International
Society for Cardiovascular Surgery, North American
Chapter, meeting, no significant differences with regard to
most endpoints were observed between the prospective and
the retrospective part. The rate of procedural complications
was slightly higher in the prospective cohort. This was reas-
suring because this indicated that the occurrence of compli-
cations was no reason that the initial nine centers, from
which the retrospective data were retrieved, had provided
incomplete information.
DISCUSSION
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With regard to the different device types, homemade
devices were not included in this study. Five types of com-
mercially available devices had been used in this patient
material. Again, this illustrated the present day practice of
endovascular abdominal aortic aneurysm treatment.
Your final question was on the imaging techniques
used. The preoperative assessment was not strictly uni-
form between the different participating institutions. For
the preoperative workup, usually a combination of DSA
and computed tomographic scanning was used, whereas
for follow-up examination, a regular computed tomo-
graphic examination was part of the routine schedule.
Thank you.
APPENDIX. EUROSTAR COLLABORATIVE
CENTERS
Amsterdam, The Netherlands; Arnhem, The
Netherlands; Athens, Greece; Barcelona, Spain;
Bonheiden-Dendermonde, Belgium; Bonn, Germany;
Bournemouth, United Kingdom; Bristol, United
Kingdom; Creteil, France; Draguignan, France;
Dublin, Ireland; Düsseldorf, Germany; Eindhoven,
The Netherlands; Enschede, The Netherlands;
Frankfurt, Germany; Freiburg, Germany; Gilly,
Belgium; Glasgow, United Kingdom; Groningen-
University Hospital, The Netherlands; Groningen-
Martini Hospital, The Netherlands; Hannover,
Germany; Heidelberg, Germany; Hull, United
Kingdom; Leuven, Belgium; Lille, France; Liverpool,
United Kingdom; London, United Kingdom; Lublin,
Poland; Lund, Sweden; Luxembourg, Luxembourg;
Lyon, France; Madrid-Hospital La Paz, Spain; Madrid-
Hospital Gregorio Maranon, Spain; Manchester,
United Kingdom; Modena, Italy; Munich, Germany;
Nancy, France; Newcastle-upon-Tyne, United
Kingdom; Nieuwegein, The Netherlands; Oslo-Aker
Hospital, Norway; Oslo-Ulleval Hospital, Norway;
Paris, France; Regensburg, Germany; Rotterdam, The
Netherlands; San Sebastian, Spain; Stockholm,
Sweden; Tilburg-Elisabeth Hospital, The Netherlands;
Tilburg-Tweesteden Hospital, The Netherlands;
Toulouse, France; St Truiden, Belgium; Trondheim,
Norway; Ulm, Germany; Utrecht, The Netherlands;
Veldhoven, The Netherlands; Vienna, Austria; Zürich,
Switzerland.
